Professional Documents
Culture Documents
~//
#
Mature
(1R:5P)
/
/
&l
/#
/
/ /
ent m values are obtained for each
inhibitor. Consequently:
(Dh. (Dh
e,--~'C', = 1
(Dm)l tu,,,)2
(5)
results and their interpretation. The conclu-
sions to be drawn are given below. when (D)I + (D)2 concentrations are such
as to produce (f,)1.2 = 0.5. I f D 1 is rotenone
Linear regression, analysis and D2 is pyrethrins, we can substitute the
The system obeys the median effect equa- values given in Table 11 into equation 5.
tion remarkably well and the results are For the experiments of the first series
highly reliable (undoubtedly because a (ratio of rotenone to pyrethrins = 1:5), we
large number of flies were used). The linear obtained (Table II) (Dmh = 0.157, (Dm)z
regression coefficients for the six = 0.910, and (Dm)l,l = 0.450 mg mi-L
dose-response series (each at five concen- Now, for this series 0.450 mg mi-x of the
trations) lie between 0.983 and 0.996, and mixture consists of 0.075 mg mi-x of
four of the values o f r are 1> 0.994. Since Mlxtu
rotenone (1/6) and 0.375 mg mi-1 of pyre-
the regression coefficients are close to 1, -10 -1'0 -o's ~ 0s thrins (5/6). Hence:
the effect produced by a given dose or the
Log D (rag ml ')
dose required to produce a given effect can ( D h ~ (D)2 0.075 0 375
- - - - - +-'~'- =0.890
be calculated from a rearrangement of Fig. 2. Lethality of rotenone and pyrethrins for (Dm)l (Dm)2 0.157 0.910
.
Equation 1 and the knowledge that house-flies. The results (Table land Fig. 1) are plot-
ted by the median-effect plot, i.e. log (fa/fu) with For the experiments of the second series
f i + f i = l:
respect to log (D). The symbols are the same as for
Fig. 1. The lines are drawn by linear regression
(ratio of rotenone to pyrethrins = 1:15), we
analysis: first series ( - - ) , second series (- - -). The obtained (Table II) (Dm)l = 0.144, (Din)2
1
parameters obtained from the linear regression = 0.868, and (Dm)t,~ = 0.652 mg mi-L
f" = 1 + (Din/D)m (4)
analysis of the plots are summarized in Table IL Now, 0.652 mg mi-~ of the mixture con-
sists of 0.041 mg m1-1 of rotenone (1/16)
Higher order and 0.611 mg ml -x of pyrethrins (15/16).
As expected from the sigmoidal curves of A r e the combined effects o f rotenone and Hence:
Fig. 1, the system is 'higher order'. The pyrethrins additive, synergistic or
slopes of plots for the single drugs and the antagonistic? -
(D)I
- q-
(D)z
- -
0.041 0.611
mixtures are remarkably similar (m = This question has been the subject of debate (Dm)~ (Din)2 0.144 q-0.----~ = 0.989
2.52_+0.15). The parallel nature of these by a number of investigators (see summary
lines suggests that the two insecticides are by Finney s, p. 149). Analysis by the We conclude that the 1:15 mixture of insec-
'mutually exclusive' (e.g. have similar median effect principle is now illustrated. ticides gives an effect which is strictly addi-
modes of action). It is hazardous, if not Since we have already shown that the tive (less than 1% deviation from unity in
impossible, in this type of experiment to system is higher order (m ~> 1 ), equation 3 the above equations), whereas the 1:5 mix-
ascribe a physical meaning to sigmoidlcity. should be used. Note, however, that at the ture is mildly synergistic (0.89) by 11%
In isolated systems (e.g. enzymes, hemo- specific dosage of the drug c o m b i n a t i o n under the specified conditions where the
globin), simpler than those involving death producing a median effect, i.e. when (fi)x.2 mixture produces a 50% fly kill. This con-
as an end-point, this property is rationalized = ffuh.2 = 0.5, the value of (fa)l,i/(fu)Ll = clusion is in agreement with those obtained
by the presence of more than one binding 1, and the value of m becomes irrelevant by the application of probit analysis as dis-
site for each ligand. since 1m = 1 for all values of m. Thus, cussed by Finney 8.
equation 3 can be evaluated under these dr- By the use of equation 3, we may calcu-
Median effect dose: absolute and relative
potencies
TABLE H. Analysis of toxicity of rotenone and pyrethrins, alone and in mixtures to house-flies.
The data from Table I were analysedaccordingto the relation, log (fa/fu) = m log D - m log Din, or the median-
The reproducibility between two series is effect plot, y = log (fa/fu)v. x = log (D) (see Fig. 2).
excellent and accurate toxicity data are
obtained. Thus, theDm (EDso) values in the Median effect
two series for rotenone are 0.157 and 0.144 dose a Lmear regression
mg ml -~ and for pyrethrins are 0.910 and Dm (EDs,) Slope of plot b coefficient
0.868 mg mi-~, respectively. Furthermore, Insecticide ( m g m1-1) m r
late the contribution of each drug in the TABLEIlL Comparisonof calculatedand observedlethalgiasof rotenoneand pyrethrmsm combination
combinations to the lethalities, assuming
Total dose (concentration) Calculated a Observed
summation of effects. This has been done of insecticides fracaonal fractional
for each concentration of the mixture of in combinations Dose conmbuted by lethality lethality
rotenone and pyrethrins for both series mg ml -~ rotenoue pyrethrms [tfah.~] [(faha]
(Table III). The fly kill predicted and that
Rotenone Pyrethnns
observed agree very closely for the series in First series (Rotenon¢: Pyrethrins = 1'5)
which the rotenone to pyrethrins ratio was 0.30 0.05 0.25 0.200 0,27
1:15. For four of the five concentrations 0.45 0.075 0.375 0.423 0.53
used, the difference between predicted and 0.60 0.10 0.50 0.611 0.64
calculated values was 5% or less, whereas 0.875 O. 1458 0.7292 0.809 0,82
for the fifth value, the difference was 8%. 1.175 O. 1958 0.9792 0.903 0,93
The differences showed no marked devia- Second series (Rotenone:Pyrethrms = 1.15)
tion from summation in the experimental 0.40 0.025 0.375 0.231 0.23
dose-effect range. In contrast, for the mix- 0.60 0 0375 0.5625 0.443 0.48
ture containing the insecticides in a ratio of 0.80 0.050 0.750 0.613 0.61
1.20 0.0750 I. 125 0.807 0.76
1 part rotenone to 5 parts pyrethrins, the
1.60 0.1(30 1.50 0.893 0.93
observed fly kill was always higher than
that predicted for summation. Thus, there aThe calculated fractional lethahty [(J'ah a] was obtained from the equauon 3:
was synergism at all concentrations; and
the synergism was most prominent at lowfo
(f.),j L(D,,,), (Dm),J
values: thus the value forfi = 0.27 (27%
kill) was 35% larger than predicted. where (D), and (D,,,)Ireferto to.none, and (D)I and (D,,,). referto pyrethrins. A meanvalueof slope(m) was
used, i.e. from Table IL for the first series m (rotenonc) ts 2.757 and m (pyrethrins) is 2.528. hence m = 2.643.
The isobologram procedure is difficult to Sample calculaOon for 0.60 mg ml ' of both drugs m first series.
apply to the available data because it (D,nh = 0.157 mg ml-'; (D,n)s = 0.910 mg m l - '
requires many more measurements. To the
very limited extent that it can be applied (fa),.s=F0.10 + 0 5 0 12.643 = 1.1864),() = 1.5711
(fuha L0 157 0.910 _1
without extrapolation, its conclusions are in
harmony with those obtained by the median (fa)xa = 1.5711 (fu)x.a, but since (fu)x,2 ~ [I - (fa),J]
effect concept. (,fa)~,~ = 1.5711 [(l -- ora),.s] = 0.6110
Note that in a hypothetical simafon when the values of m , and m s are markedly different, the use ofm = (m, 4-
The product of fractional activities gives
ms)/2 may not be a good apptoxinumon o f m l a , in this circumstance, the method of using equaUon 5 at tfa h.2 =
startlingly different resdts. There is one set 0.5 [i.e. at (Dmh.*] Is recommended (as iUnstrated m the text) since the magnitudes of m , and ms can be &sre-
of values from each series which can be garded under this resmcted con&tion.
used directly (Table IV), but the same con-
clusions apply to all values, if one interpol- effects has been derivedL I! has an addi- intercept the plot of the more potent of the
ates over the required range. In both series, tionalterm when compared with equation 3 two drugs. The theoretical plot for equation
this analysis indicates that the drugs show and is given by: 6 and experimental examples have been
very marked synergism. We believe this to provided recently (see Ref. 3 for details).
indicate that this method (based on
restricted mechanistic assumptions) is not ~'~J
[
(foh~l.-L (Dh
= (-D~.h + ~
(D)2 (Dh(D)2
+ (Dm),(D..~ General utility of median effect analysis
adequate to describe summation of com- We have demonstrated that application
(6) of the median effect equation to whole ani-
bined drug effects in this system. As indi-
cated earliers, the fractional product When the mixture of mutually nonexclu- mal toxicity data leads not only to rigorous
method applies only under the following sire drugs is used, the median-effect plot of definition of summation of drugs effects but
conditions: (i) the effects of the drugs are y ~- log [(fah~/(f,),~] with respect to x = also provides a cost-effective analysis and
mutually nonexclusive (i.e. the drugs act log [(Dh + (Dh] will give a concave additional information about the properties
independently of one another), (ii) the upward curve which at high doses will of the system. Unfortunately, there are very
dose-effect curves for both drugs are
hyperbolic (Michaelis-Menten or first TABLE IV. Comparison of the fractional product method and the ixesent method
order). In the present example, neither of Insect~kle F ~ fly ~1 ¢fi)
these criteria applies, and consequently the and dose Calculatedby Webb's Calculated by the present
fractional product method gives erroneous (nagm F ~) Obsctvc(I method assumingaddiuvity" method assuming ndditivay b
results.
First series
Romnone, 0. I 0.24
What happens if the effects of two drugs pmthrths, 0.5 0.20
are mutually nonexclnsive? Mixture, rotenone, 0.1
The above example for rotenoue and pins pyrethrins, 0.5 0.64 0.392 0.611
pyrethrins indicates that the effects of both Second seams
drugs are mutually exclusive (i.e. parallel Rotenon¢, 0.1 0.28
median-effect plot for the mixture as shown Pyrmhrim, 1.5 0.72
Mixture, rocenone, O. I
in Fig. 2). For the situation when the effects
plus pytethrins, l 5 0 93 0 798 0 893
of both drugs are mutually nonexclusive
(i.e. the drugs have different modes of • C_~culated ~ m [ I - (f,,),.) = [ I - (f,,).) 11 - (f.).) or q',,).. = ( f . ) , x ( f . ) . .
action or act independently) the general b Calculat~ froHI the eqttagion 8.s iUusuag~ Ill Table m . Note that all other combinauons that were calculated with
equation for describing the summation of the present method according to Table Ill cannot be calculated with Webb's method
454 TIPS - N o v e m b e r 1983
few experiments on drug or toxicity effects 3 Chou, T.-C. and Talalay, P. (1981) Eur. J. 16 Chou, T.-C., Burchenal, J. H., Schmid, F. A.,
Biochem. 115, 207-216 Braun, T. J., Su, T.-L., Watanabe, K. A., Fox,
which have been designed appropriately for
4 Chou, T.-C. (1976)J. Theor. Biol. 59,253-276 J. J. and Philips, F. S. (1982) Cancer Res. 42,
this type o f analysis. O n e needs concentra-
5 Chou, T.-C. (1977)J. Theor. Biol. 65, 345--356 3957-3963
tion-effect curves for each drug alone and 6 Chou, T.-C. and Talalay, P. (1977) J. Biol. 17 Chou, T.-C. (1980) Carcinogenesis 1,203-213
for at least one constant ratio mixture. Chem. 252, 6438-6442 18 Teller, M. N., Stock, C., Bowie, M., Chou, T.-C.
The identical principles have been 7 Bonnias, M. (1982) Biochem. Pharmacol. 31, and Budinger, J. M. (1982) Cancer Res. 42,
recently applied successfully to the simple 2769-2775 4408-4412
and efficient analysis o f the effects o f mul- 8 Finney, D. J. (1952) in ProbitAnalysis, 2ndedn, 19 Murphy, K. M. M. and Snyder, S. H. (1982)Mol.
tiple inhibitors on e n z y m e s (Chou and pp. 146-153, Cambridge University Press, Cam- Pharmacol. 22, 250-257
bridge 20 Smith, S. W. (1982)J. Theor. Biol. 98, 475--499
Talalay s, Kremer et al.ra; Finotti and
9 Le Pelley, R. H. and Sullivan, W. N. (1936) J.
Palatinial; Steckel et al. ~). In each case the Econ. Entomol. 29, 791-797
method provided information on whether Ting-Chao Chou was born m Taiwan, receivedhis
10 Kremer, A. B., Egan, R. M. and Sable, H. Z. Ph.D. in Pharmacologyfrom Yule Universityand
or not s u m m a t i o n of inhibitor effects was (1980)J. Biol. Chem. 255, 2405-2410 his postdoctoral training at The Johns Hopkins
observed, whether the inhibitors were 11 Finotti, P. and Palatini, P. (1981)J. Pharmacol. University. He is now an Associate Member at
mutually exclusive or nonexclusive, and Exp. Ther. 217,784-790 Memorial Sloan-Kettering Cancer Center and
whether the system was f a s t or higher 12 Steckel, J., Roberts, J., Philips, F. S and Chou, Associate Professor of Pharmacology at Cornell
T.-C. (1983) Biochem. Pharmacol. 32, 971-977 University GraduateSchool of MedicalSciences.
order. All of these conclusions could he
13 Chou, T.-C. (1974) Mol. Pharmacol. 10,
drawn without knowledge of conventional 235-247
Paul Tululayis the John Jacob Abel Distinguished
kinetic constants (gm, Vma~ or KL) and 14 Friedman, S. J. and Skehan, P. (1980) Proc. Natl Service Professor of Pharmacology and Experi-
involved no assumptions whether the Acad. Sci. USA 77, 1172-1176 mental Therapeuticsat Johns Hopkins University
Medical School and a former director of this
m e c h a n i s m of inhibition was competitive, 15 Rosenberg, R. (1981) Biochem. Biophys. Acta
649, 262-268 department.
non-competitive or uncompetitivea,6,ra.
Note added in proof:
Furthermore, the median effect equation After submission of this paper, an improved method for calculating the drug combination index (CI) at
has been used to obtain accurate values various effect levels has been developed. Equation (5) has been extended to define CI for two drugs as follows:
o f ID6o, EDso or LDso in enzyme sys- CI = (D)l/(Dx)l + (D)~J(Dx)2,where (D01 and (D0"- are the doses required to achieve a gwen effect level
for each drug, Le. a specified value offa; (D)l and (D)e are the doses of each drug m a given mixture which
tems a-7,xo.aa,~a, in cellular systemsx4-x~, gives the same fa. When C1 values are 1, < 1, or > 1, It may be concluded that summation, synergism, or
and in animal systems xT,ra. An alternative antagomsm, respectively, have been observed at the particular effect level examined.
form o f the median-effect equation xa has Computer programs for automated analysis have been written and may be obtained from the authors. A
been used for calculating the dissociation more detaded description will be pubhshed (T.-C Chou and P. Talalay (1984)Advancesin Enzyme Regulanon
23, m press).
constant (K,) o f ligands for pharmacologi-
cal receptorsra. It has also permitted t h e
analysis of chemical carcinogenesis data,
and predicted especially accurately tumor
incidence at low dose carcinogen
exposuretL By using the median-effect
principle, the general equation for describ-
ing a standard radioimmunoassay or ligand
H o r m o n e s and
displacement curve has been derived
recently by Smith 2°. It has also been used to
show that there is marked synergism a m o n g
n e u r o t r a n s m i t t e r s in
chemotherapeutic agents in the treatment of
hormone responsive experimental m a m -
milk
mary caxcinomasra. It is perhaps surprising E. Hazum
that the median-effect analysis appears to Department of Hormone Research, The Weizmann Instituteof Science, Rehovot, 76100, Israel.
be valid for the analysis o f systems in which
both quantal (all-or-none) and graded Several hormones and neurotransmitters are present in milk f r o m humans and other
effects are being measured. mammals, e.g. gonadotropin-releasing hormone, thyrotropin-releasing hormone,
The future epidermal growth factor, morphiceptin and fl-casomorphin, morphine, TSH,
It appears likely that the median effect A C T H , prolactin, gonadotropins, etc. The presence of significant quantities o f these
principle and plot will permit analysis o f hormones and neurotransmitters in milk raises the question not only o f their role but
combinations o f effectors o f various other also o f their origin. They can be synthesized or processed in the m a m m a r y gland or
types. In order to examine its validity, we excreted into milk through various pathways. In the suckling mammals, the hormones
hope that other workers will bring to our and neurotransmitters may gain entrance into the body through the gastrointestinal
attention suitable data or will consult us tract and could have physiological and pharmacological significance by interacting
regarding the analysis o f their o w n data. with their specific receptors.
Acknowledgements
The authors receive research support from Introduction importance and have evolved differently,
the National Institutes of Health (AM 07422 Milk is a mammal-specific biological both in quality and quantity, to m e e t t h e
and CA 27569) and from the American Cancer fluid. It is the f'ast and sole food of newborn specific requirements o f neonatal develop-
Society (SIG-3). m a m m a l s for a certain period o f time. The ment in various m a m m a l s . The unique sig-
neonatal phase is characterized by rapid nificance o f milk as a food for the neonate
Reading list
growth and development o f several organs has resulted in the biochemical aspects o f
1 Loewe, S. (1957)Pharmacol. Rev. 9, 237-242
2 Webb, J. L. (1963) m Enzymes and Metabolic including the liver, kidneys and endocrine milk being extensively investigated since
lnhibitors, Vol. 1, pp. 66-79 and 487-512, glands, which are not fully formed at birth. t h e early eighteenth century.
AcademicPress, New York Therefore, the milk constituents are o f great The composition of milk changes with
© 1983 ElsevterScience PubhshersB V , Amsterdam 0165- 6147/83/$01 00